Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$72.54 - $95.56 $157,049 - $206,887
2,165 New
2,165 $206,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $99,215 - $147,125
-1,147 Reduced 11.53%
8,797 $837,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $60,564 - $76,233
-594 Reduced 5.64%
9,944 $1.17 Million
Q4 2021

Jan 18, 2022

SELL
$106.37 - $130.68 $86,372 - $106,112
-812 Reduced 7.15%
10,538 $1.37 Million
Q3 2021

Nov 03, 2021

BUY
$102.91 - $122.75 $754,124 - $899,512
7,328 Added 182.2%
11,350 $1.29 Million
Q2 2021

Jul 29, 2021

BUY
$83.84 - $104.76 $58,939 - $73,646
703 Added 21.18%
4,022 $417,000
Q1 2021

May 04, 2021

SELL
$78.68 - $90.67 $84,895 - $97,832
-1,079 Reduced 24.53%
3,319 $278,000
Q4 2020

Jan 14, 2021

BUY
$71.69 - $91.23 $69,324 - $88,219
967 Added 28.18%
4,398 $401,000
Q3 2020

Nov 02, 2020

SELL
$67.19 - $87.44 $222,734 - $289,863
-3,315 Reduced 49.14%
3,431 $274,000
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $255,765 - $342,042
4,445 Added 193.18%
6,746 $466,000
Q1 2020

Apr 30, 2020

BUY
$52.41 - $81.0 $19,496 - $30,132
372 Added 19.28%
2,301 $434,000
Q4 2019

Jan 29, 2020

BUY
$71.7 - $82.09 $2,007 - $2,298
28 Added 1.47%
1,929 $450,000
Q3 2019

Oct 31, 2019

BUY
$61.55 - $75.43 $1,846 - $2,262
30 Added 1.6%
1,901 $418,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $7,692 - $8,888
138 Added 7.96%
1,871 $346,000
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $1,580 - $2,113
-33 Reduced 1.87%
1,733 $332,000
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $6,404 - $7,857
138 Added 8.48%
1,766 $270,000
Q3 2018

Oct 09, 2018

SELL
$45.7 - $58.03 $153,323 - $194,690
-3,355 Reduced 67.33%
1,628 $283,000
Q2 2018

Aug 01, 2018

BUY
$42.45 - $51.3 $32,941 - $39,808
776 Added 18.45%
4,983 $725,000
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $84,532 - $107,853
2,273 Added 117.53%
4,207 $587,000
Q4 2017

Feb 01, 2018

BUY
$33.79 - $39.39 $65,349 - $76,180
1,934
1,934 $218,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.